These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 22081058

  • 1. Do elderly patients with metastatic cancer have worse quality of life scores?
    Koo K, Zeng L, Chen E, Zhang L, Culleton S, Dennis K, Caissie A, Nguyen J, Holden L, Jon F, Tsao M, Barnes E, Danjoux C, Sahgal A, Chow E.
    Support Care Cancer; 2012 Sep; 20(9):2121-7. PubMed ID: 22081058
    [Abstract] [Full Text] [Related]

  • 2. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy.
    Caissie A, Culleton S, Nguyen J, Zhang L, Zeng L, Holden L, Dennis K, Chan E, Jon F, Tsao M, Danjoux C, Sahgal A, Barnes E, Koo K, Chow E.
    Support Care Cancer; 2012 Apr; 20(4):841-8. PubMed ID: 21538099
    [Abstract] [Full Text] [Related]

  • 3. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A, Nguyen J, Chen E, Zhang L, Sahgal A, Clemons M, Kerba M, Arnalot PF, Danjoux C, Tsao M, Barnes E, Holden L, Danielson B, Chow E.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1238-45. PubMed ID: 22172909
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Verification of the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 palliative (EORTCQLQ-C15-PAL).
    Miyazaki K, Suzukamo Y, Shimozuma K, Nakayama T.
    Qual Life Res; 2012 Mar 15; 21(2):335-40. PubMed ID: 21643874
    [Abstract] [Full Text] [Related]

  • 9. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L, Wang N, Zhang J, Liu J, Luo Z, Sun W, Woo SM, Chen C, Zhang K, Miller AR, Guo H, Zhang X, Wang C.
    Palliat Med; 2016 Apr 15; 30(4):401-8. PubMed ID: 26121985
    [Abstract] [Full Text] [Related]

  • 10. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Radiother Oncol; 2016 May 15; 119(2):208-12. PubMed ID: 27157890
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
    McDonald R, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar R, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.
    Support Care Cancer; 2016 Dec 15; 24(12):4871-4878. PubMed ID: 27465049
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
    Rojas-Concha L, Hansen MB, Petersen MA, Groenvold M.
    BMC Palliat Care; 2020 Jun 09; 19(1):81. PubMed ID: 32517678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.